T1	21 24	Raf
T2	25 28	Mek
T3	29 32	Erk
T4	44 50	kinase
T5	249 257	oncogene
T6	265 293	non-small celllung carcinoma
T7	295 300	NSCLC
T8	326 329	Erk
T9	330 336	kinase
T10	355 360	K-Ras
T11	431 437	Erk1/2
T12	454 471	tumor development
T13	489 498	lethality
T14	502 512	adult mice
T15	527 533	Mek1/2
T17	666 669	RAs
T18	734 739	A-Raf
T19	752 758	c-Raf.
T20	741 746	B-Raf
T16	1189 1201	mutant tumor
T21	1235 1253	anti-tumor effects
T22	1261 1271	inhibition
T23	1444 1458	adenocarcinoma
T24	1486 1495	tamoxifen
T25	1466 1482	treatment method
